Richard W. Keatinge, Ph.D., Chief Business Officer
Richard Keatinge is a graduate of the University of California, Berkeley, and holds a Ph.D. from Harvard University. He has more than 20 years of biotechnology industry experience in both the U.S. and Europe. Prior to joining Cytheris in September 2007, he was a Managing Director and Vice President of Business Development at BioAlliance Pharma, Paris, where he played a key role in the successful flotation of the company on NYSE Euronext. Previously, he held positions as Vice President of Corporate Development at FeRx Inc. and Vice President of Business Development at Digital Gene Technologies. Earlier in his career, he was Director of Corporate Communications at ICN Pharmaceuticals (NYSE:VRX).